We know the success of stem cell therapy for knee arthritis is exceptional based on patient feedback and clinical studies, such as the 2018 review in Pain Physician. For under $4000, patients can receive treatment into both knees and two other joints!
SCOTTSDALE, Ariz. (PRWEB) July 20, 2020
R3 Stem Cell International is offering a new program for stem cell therapy for knees in Mexico. The program includes either 30 or 50 million live stem cells in either the Tijuana or Medical clinic.
Stem cell treatment for knees is a great opportunity to help patients avoid the need for potentially risky surgery, such as a joint replacement. The stem cell biologic used by R3 International in Mexico includes safety standards that actually exceeds FDA regulations.
Treatment for knee arthritis is only $2950 for 30 million cells, which is actually enough to treat both knees. This amounts to an exceptional offer for an amount over 70% less than what knee therapy cost in the US. If an individual desires treatment with 50 million live stem cells, the cost is only $1000 more. This is enough to treat four joints for a patient who has arthritis in several areas.
According to R3 CEO David Greene, MD, MBA, "We know the success of stem cell therapy for knee arthritis is exceptional based on patient feedback and clinical studies, such as the 2018 review in Pain Physician. For under $4000, patients can receive treatment into both knees and two other joints!"
The process at R3 International begins with a free phone consultation with a licensed, experienced stem cell doctor. Once the recommendation ensues and a patient schedules, a dedicated concierge representative assists with all travel logistics. R3 provides transportation from San Diego airport to the clinic, which is only 20 minutes from the airport.
In addition to stem cell treatment for knees, R3 offers stem cell treatment for COPD in Mexico, along with kidney failure, diabetes, stroke, heart failure, Lyme and more. Call (888) 988-0515 to schedule and visit https://stemcelltreatmentclinic.com for more information.